80 related articles for article (PubMed ID: 20712874)
21. Sperm protein 17, MAGE-C1 and NY-ESO-1 in hepatocellular carcinoma: expression frequency and their correlation with clinical parameters.
Xia QY; Liu S; Li FQ; Huang WB; Shi LN; Zhou XJ
Int J Clin Exp Pathol; 2013; 6(8):1610-6. PubMed ID: 23923079
[TBL] [Abstract][Full Text] [Related]
22. Identification of vascular and hematopoietic genes downstream of etsrp by deep sequencing in zebrafish.
Gomez G; Lee JH; Veldman MB; Lu J; Xiao X; Lin S
PLoS One; 2012; 7(3):e31658. PubMed ID: 22438865
[TBL] [Abstract][Full Text] [Related]
23. Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis.
Cheng YH; Wong EW; Cheng CY
Spermatogenesis; 2011; 1(3):209-220. PubMed ID: 22319669
[TBL] [Abstract][Full Text] [Related]
24. In vivo molecular targeting effects of anti-Sp17- ICG-Der-02 on hepatocellular carcinoma evaluated by an optical imaging system.
Li FQ; Zhang SX; An LX; Gu YQ
J Exp Clin Cancer Res; 2011 Mar; 30(1):25. PubMed ID: 21366930
[TBL] [Abstract][Full Text] [Related]
25. Molecular staging of gynecological cancer: What is the future?
Binder PS; Prat J; Mutch DG
Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):776-89. PubMed ID: 25934522
[TBL] [Abstract][Full Text] [Related]
26. Sperm protein 17 is an oncofetal antigen: a lesson from a murine model.
Arnaboldi F; Menon A; Menegola E; Di Renzo F; Mirandola L; Grizzi F; Figueroa JA; Cobos E; Jenkins M; Barajon I; Chiriva-Internati M
Int Rev Immunol; 2014 Oct; 33(5):367-74. PubMed ID: 24811209
[TBL] [Abstract][Full Text] [Related]
27. Sperm protein 17 is highly expressed in endometrial and cervical cancers.
Li FQ; Liu Q; Han YL; Wu B; Yin HL
BMC Cancer; 2010 Aug; 10():429. PubMed ID: 20712874
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of sperm protein 17 expression and immunogenicity in esophageal cancer.
Gupta G; Sharma R; Chattopadhyay TK; Gupta SD; Ralhan R
Int J Cancer; 2007 Apr; 120(8):1739-47. PubMed ID: 17230514
[TBL] [Abstract][Full Text] [Related]
29. Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.
Gjerstorff MF; Pøhl M; Olsen KE; Ditzel HJ
BMC Cancer; 2013 Oct; 13():466. PubMed ID: 24103781
[TBL] [Abstract][Full Text] [Related]
30. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.
Brunette LL; Mhawech-Fauceglia PY; Ji L; Skeate JG; Brand HE; Lawrenson K; Walia S; Chiriva-Internati M; Groshen S; Roman LD; Kast WM; Da Silva DM
BMC Cancer; 2018 Oct; 18(1):970. PubMed ID: 30309325
[TBL] [Abstract][Full Text] [Related]
31. DeltaNp63 protein expression in uterine cervical and endometrial cancers.
Lin Z; Liu M; Li Z; Kim C; Lee E; Kim I
J Cancer Res Clin Oncol; 2006 Dec; 132(12):811-6. PubMed ID: 16804722
[TBL] [Abstract][Full Text] [Related]
32. Anti-Sp17 monoclonal antibody with antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activities against human ovarian cancer cells.
Song JX; Cao WL; Li FQ; Shi LN; Jia X
Med Oncol; 2012 Dec; 29(4):2923-31. PubMed ID: 22198696
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of human sperm protein 17 increases migration and decreases the chemosensitivity of human epithelial ovarian cancer cells.
Li FQ; Han YL; Liu Q; Wu B; Huang WB; Zeng SY
BMC Cancer; 2009 Sep; 9():323. PubMed ID: 19744347
[TBL] [Abstract][Full Text] [Related]
34. Sperm protein 17 is expressed in the sperm fibrous sheath.
Chiriva-Internati M; Gagliano N; Donetti E; Costa F; Grizzi F; Franceschini B; Albani E; Levi-Setti PE; Gioia M; Jenkins M; Cobos E; Kast WM
J Transl Med; 2009 Jul; 7():61. PubMed ID: 19604394
[TBL] [Abstract][Full Text] [Related]
35. Sperm protein 17 is a suitable target for adoptive T-cell-based immunotherapy in human ovarian cancer.
Chiriva-Internati M; Weidanz JA; Yu Y; Frezza EE; Jenkins MR; Kennedy RC; Cobos E; Kast WM
J Immunother; 2008 Oct; 31(8):693-703. PubMed ID: 18779750
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
